IDH1/IDH2 Inhibition in Acute Myeloid Leukemia.

Front Oncol · 2021 · PMC8063727 · PMID 33898313

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

In the first large retrospective study, there was a possible trend of inferior response and survival in dual mutants treated with lower intensity FLT3 inhibitor based regimens, particularly in the older AML population ( 61 ).

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.